MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):29-35. doi: 10.15585/mmwr.mm7002a1.
Screening for breast cancer, cervical cancer, and colorectal cancer (CRC) reduces mortality from these cancers.* However, screening test receipt has been below national targets with disparities observed in certain populations (1,2). National Health Interview Survey (NHIS) data from 2018 were analyzed to estimate percentages of adults up to date with U.S. Preventive Services Task Force (USPSTF) screening recommendations. Screening test receipt remained below national Healthy People 2020 (HP2020) targets, although CRC test receipt neared the target. Disparities were evident, with particularly low test receipt among persons who were uninsured or did not have usual sources of care. Continued monitoring helps assess progress toward targets and could inform efforts to promote screening and reduce barriers for underserved populations.
筛查乳腺癌、宫颈癌和结直肠癌（CRC）可以降低这些癌症的死亡率。* 然而，筛查检测的接受率低于国家目标，某些人群存在差异（1,2）。对 2018 年国家健康访谈调查（NHIS）数据进行了分析，以估计符合美国预防服务工作组（USPSTF）筛查建议的成年人比例。尽管 CRC 检测的接受率接近目标，但筛查检测的接受率仍低于国家健康人 2020 年（HP2020）目标。存在明显的差异，特别是在没有保险或没有常规医疗来源的人群中，检测接受率特别低。持续监测有助于评估实现目标的进展情况，并为促进服务不足人群的筛查和减少障碍提供信息。
